Malaria Medication for Sub-Sahara
08/03/07 13:40 | Morocco Articles
In a recent press release from Paris, Morocco has stated that it is helping its sister countries with a new “simplified and low-cost” treatment for malaria for those who suffer from the disease in sub-Saharan African countries. The new treatment, from the pharmaceutical group of Sanofi-Aventis has been dubbed ASAQ and will drastically help countries where malaria kills nearly one million people per year.
The new treatment, which will be released over the next year, will cost twice as much for adults as for children, because they need twice the dose of effective treatment. The total cost will be USD .50 for children and USD 1.00 for adults – the cheapest treatment ever released.

Robert Sebagg, who spoke at the news conference, said that the new treatment is a partnership between Sanofi-Aventis and an initiative known as called DNDi (Initiative pour des médicaments en faveur des maladies négligées). The factory that will produce the malaria treatment, located in Casablanca, will produce millions of doses per year that will be taken and marketed in the sub-Saharan African countries most in need. Many hope that the un-patented production and sales will keep the cure affordable for those who once couldn’t afford the medication.

Brought to you by: Morocco News at Journey Beyond Travel
Source: Maghreb Arabe Presse

Tags: